Last reviewed · How we verify
Placebo (for Lactoferrin)
A placebo contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect.
A placebo contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect. Used for Control arm in lactoferrin clinical trial (indication under investigation).
At a glance
| Generic name | Placebo (for Lactoferrin) |
|---|---|
| Sponsor | Ain Shams University |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Placebos are inert substances used as controls in clinical trials to measure the effect of expectation and psychological factors on patient outcomes. In this case, the placebo is being compared against lactoferrin, an iron-binding protein with potential antimicrobial and immunomodulatory properties. The placebo arm allows researchers to isolate the true pharmacological effects of lactoferrin from psychological and contextual healing effects.
Approved indications
- Control arm in lactoferrin clinical trial (indication under investigation)
Common side effects
Key clinical trials
- Antibacterial Mouthwash for Pharyngeal Gonorrhea Prevention (PHASE2)
- Bovine Colostrum for Prophylaxis Against Recurrent Urinary Tract Infection in Children (PHASE2)
- Efficacy of Recombinant Bovine Lactoferrin (rbLf) in Iron Regulation (NA)
- Lactoferrin and Lysozyme Supplementation for Long-term Diarrhea Sequelae (PHASE3)
- 4-day Plaque Accumulation Model Evaluating Compound Containing Gum (NA)
- Prophylaxis of Febrile Neutropenia With Lactoferrin in Oncohematologic Children Undergoing Induction Chemotherapy (NA)
- Palatal Mucosa Wound Healing Following Antimicrobial Gel Application (NA)
- Clinical Comparison of a Postbiotic-gel With Placebo Gel for Gingival Inflammation in Patients With Down Syndrome (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo (for Lactoferrin) CI brief — competitive landscape report
- Placebo (for Lactoferrin) updates RSS · CI watch RSS
- Ain Shams University portfolio CI